Pacira Biosciences, Inc. (PCRX)
25.22
+0.36
(+1.45%)
USD |
NASDAQ |
Aug 25, 13:37
Pacira Biosciences Total Liabilities (Quarterly) : 572.00M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 572.00M |
| March 31, 2026 | 554.64M |
| December 31, 2025 | 571.81M |
| September 30, 2025 | 570.36M |
| June 30, 2025 | 779.50M |
| March 31, 2025 | 788.13M |
| December 31, 2024 | 775.17M |
| September 30, 2024 | 772.11M |
| June 30, 2024 | 767.54M |
| March 31, 2024 | 691.16M |
| December 31, 2023 | 704.26M |
| September 30, 2023 | 702.91M |
| June 30, 2023 | 734.41M |
| March 31, 2023 | 755.38M |
| December 31, 2022 | 906.19M |
| September 30, 2022 | 964.24M |
| June 30, 2022 | 977.35M |
| March 31, 2022 | 1.182B |
| December 31, 2021 | 1.345B |
| September 30, 2021 | 637.40M |
| June 30, 2021 | 638.66M |
| March 31, 2021 | 636.73M |
| December 31, 2020 | 654.82M |
| September 30, 2020 | 635.58M |
| June 30, 2020 | 477.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 447.34M |
| December 31, 2019 | 476.12M |
| September 30, 2019 | 461.33M |
| June 30, 2019 | 446.19M |
| March 31, 2019 | 391.64M |
| December 31, 2018 | 368.13M |
| September 30, 2018 | 357.78M |
| June 30, 2018 | 352.17M |
| March 31, 2018 | 343.52M |
| December 31, 2017 | 348.89M |
| September 30, 2017 | 341.29M |
| June 30, 2017 | 344.70M |
| March 31, 2017 | 329.33M |
| December 31, 2016 | 172.49M |
| September 30, 2016 | 167.00M |
| June 30, 2016 | 172.35M |
| March 31, 2016 | 165.04M |
| December 31, 2015 | 171.23M |
| September 30, 2015 | 159.98M |
| June 30, 2015 | 159.71M |
| March 31, 2015 | 151.01M |
| December 31, 2014 | 154.93M |
| September 30, 2014 | 150.32M |
| June 30, 2014 | 144.11M |
| March 31, 2014 | 127.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | 10.17B |
| Liquidia Corp. | 326.80M |
| Johnson & Johnson | 116.09B |
| Merck & Co., Inc. | 87.82B |
| ANI Pharmaceuticals, Inc. | 896.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.244B |
| Shareholders Equity (Quarterly) | 671.98M |
| Debt to Equity Ratio | 0.6133 |
| Current Ratio | 5.042 |
| Net Debt Paydown Yield | 4.44% |